期刊文献+

兔乙醇胫神经干阻滞的量效关系研究

The research of dose-response relationship following alcohol-induced rabbits′ tibial nerve block
下载PDF
导出
摘要 目的:明确兔乙醇胫神经阻滞的量效关系。方法:新西兰兔24只,胫神经44条,外周神经电刺激器引导下,行胫神经无水乙醇阻滞。按注射容量分为4组:0.1ml、0.3ml、0.5ml和1.0ml。分别于阻滞前和阻滞后第1、2、4、7天及2、3、4、5、6、7、8周,记录腓肠肌复合肌肉动作电位(CMAP);实验终止时,取胫神经和注射部位肌肉行HE染色,观察组织学损害。结果:小容量0.1ml组CMAP波幅在第1周有所恢复,但第2周作用基本消失(P>0.05),而0.3ml组的作用持续到第8周(P<0.05);大容量组(0.5ml和1.0ml)CMAP波幅降低更明显(P<0.05),但并发症也显著增加。大部分动物(9/15)因并发症死亡,故实验在第4周终止。前4周CMAP波幅降低,除0.3ml与0.5ml组间差异不显著(P>0.05),其他各组间差异显著(P<0.05);组织学示各组出现不同程度神经轴索变性;0.5ml和1.0ml组肌肉局灶性结缔组织增生。结论:兔乙醇胫神经干阻滞的理想有效安全容量是0.3ml/点。 Objective: To verify the dose-response relationship in alcohol-induced rabbits′ tibial nerve block. Method: Twenty-four New Zealand white rabbits were randomly assigned to four groups based on alcohol volume (0.1ml、0.3ml、0.5ml、1.0ml). All tibial nerves were successfully located with a nerve electrical stimulator. Compound muscle action potential (CMAP) was measured on the skin surface of gastrocnemius muscle belly preintervention and at days 1, 2, 4, 7 and weeks 2, 3, 4, 5, 6, 7, 8 postblock. Histologic studies were performed to evaluate the destruction of tibial nerves and muscles. Result: In four groups, CMAP amplitude showed reduction 1 day after nerve block. In group 0.1ml, CMAP amplitude showed the smallest reduction at 1 day and recovered in 1 week after block, but the block effect disappeared at 2 week after block(P〉0.05). In group 0.3ml, the block effect last 8 weeks. In groups 0.5ml and 1.0ml, CMAP amplitudes showed maximal reduction 1 day after block 4 weeks and no increase later. There was no statistically difference between groups 0.3ml and 0.5ml (P〈0.05). Axonal degeneration was evident within the tibial nerve among all groups. Muscle desmoplasia was noted within the groups of 0.5ml and 1.0ml. Conclusion: The most effective and safest volume is 0.3ml for alcohol induced rabbits′ tibial nerve block.
出处 《中国康复医学杂志》 CAS CSCD 北大核心 2011年第7期609-614,共6页 Chinese Journal of Rehabilitation Medicine
关键词 量效关系 神经溶解技术 酒精 胫神经 复合肌肉动作电位 dose-response relationship neurolysis alcohol tibial nerve compound muscle action potential
  • 相关文献

参考文献29

  • 1Elovic E. Principles of pharmaceutical management of spastic hypertonia[J]. Phys Med Rehabil Clin N Am, 2001, 12(4): 793-816.
  • 2AI-Shahrani AM.Anti-spasticity medications[J]. Saudi Med J, 2003,24( 1 ): 19-22.
  • 3励建安,黄澎.神经溶解技术在康复治疗中的应用[J].中国临床康复,2002,6(18):2670-2671. 被引量:16
  • 4Dejong RH, Wagman IH. Physiological mechanisms of periph- eral nerve block by local anesthetics[J]. Anesthesiology, 1963, 24:684-727.
  • 5刘守国,励建安,朱杰,李冰.神经阻滞的注射针定位中电刺激强度与针尖-神经干距离及针尖斜面方向关系的实验研究[J].中国康复医学杂志,2009,24(11):981-984. 被引量:8
  • 6GOH S C,PATTIE R,BYRNE C. Blue and red laser action in Nd3+,Pr3+ codoped fluorozirconate glass[J]. Applied physics letters,1995,67(6): 768-770.
  • 7Sung DH, Han TR, Park WH, et al. Phenol block of peripher- al nerve conduction: Titrating for optimum effect[J]. Arch Phys Med Rehabil, 2001, 82(5):671-676.
  • 8Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches[J]. Pharm Stat, 2008,7 (2):93-106.
  • 9vanhoe CB, Reistetter TA. Spasticity: the misunderstood part of the upper motor neuron syndrome[J]. Am J Phys Med Re- habil,2004, 83(10 Suppl):S3-9.
  • 10Lance JW. Disordered muscle tone and movement[J]. Clin Exp Neurol, 1981, 18:27-35.

二级参考文献26

  • 1闵大六,周晓燕,杨文涛,孙孟红,陆洪芬,张太明,郑爱华,曹裴珍,施达仁.B细胞性非霍奇金淋巴瘤中BCL-6基因5′-非编码区突变[J].中华病理学杂志,2004,33(3):238-241. 被引量:6
  • 2刘建军,胡莹媛,李燕春,吴卫红,陆华宝,张雁.酚阻滞术治疗痉挛型脑瘫的疗效分析[J].现代康复,1999,3(12):1418-1419. 被引量:5
  • 3赵向荣,马大烈.Oct2蛋白在淋巴瘤中的表达及意义[J].中华病理学杂志,2005,34(6):337-340. 被引量:2
  • 4Dejong RH, Wagman IH. Physiological mechanisms of peripheral nerve block by local anesthetics [J]. Anesthesiology, 1963, 24:684 727.
  • 5Selender D, Sjostrand J. Longitudinal spread of intraneurally injected local anesthetics [J]. Acta Anaesthesiol Scand, 1978, 22(6): 622-634.
  • 6Raymond SA, Abrams SB, Raemer DB, et al. The nerve seeker: A system for automated nerve localization [J]. Reg Anesth, 1992, 17(3): 151-162.
  • 7Fanelli G, Casati A, Garancini R, et al. Nerve stimulator and multiple injection technique for upper and lower limb blockade: Failure rate, patient acceptance, and neurologic complications [J]. Anesth Analg, 1999, 88(4): 847-852.
  • 8Zafonte RD, Munin MC. Phenol and alcohol blocks for the treatment of spasticity [J]. Plays Med Rehabil Clin N Am, 2001, 12(4): 817-832.
  • 9Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity movement disorders [J]. J Child Neurol, 2003, 18 (Suppl 1): S50-66.
  • 10Gracies JM, Elovic E, McGuire J, et al. Traditional pharmacological treatments for spasticity part Ⅰ: Local treatments [J]. Muscle Nerve, 1997, 20(Suppl 6): S61-S91.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部